Report #2863299

Received Oct 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Herpes zoster

Symptom narrative

shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 5 days after receiving Shingrix, the patient experienced shingles (Verbatim: shingles). The outcome of the shingles was resolved (duration 14 months). It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 30-SEP-2025 This case was reported by a patient via interactive digital media. It was not funny at all. Patient had shingles for 14 months and developed them shortly before he turned 70. he had received the shingles vaccine 5 days earlier.